Salesforce: Is The Stock A Buy Before Q4 Earnings? (Technical Analysis, Rating Downgrade)

Summary:

  • Salesforce is heading into its earnings report week and investors may question if owning an exposure in the stock or waiting for more visibility.
  • The software application industry struggles to consistently recover despite the recent upward movement.
  • I update my valuation model for CRM and discuss important price levels and metrics that investors could consider to gain an edge over the stock’s likely price action.
  • By considering multiple outcomes and setting up an adequate contingency plan, investors are less inclined to act driven by emotions, as this could come at a higher cost.
  • Considering the likelihood of higher volatility and even further weakness, I downgrade CRM to a hold position.

From 4th to 1st quarter symbol. Turned wooden cubes and changed words "Q4" to "Q1". Beautiful grey table, grey background. Business, happy 1st quarter Q1 concept, copy space.

Dzmitry Dzemidovich/iStock via Getty Images

Salesforce, Inc. (NYSE:CRM) stock has lost 60% since the beginning of its downtrend, and while partially recovering its losses in the recent retracement, the stock is still in stage 4 and has been rejected in its breakout

Sectors 1Y vs 1M

finviz

Application Software Industry and Technology Sector 1Y vs 1M

finviz

IGV vs IXIC 23.02.2023

Author, using TradingView

CRM DCF 24.02.2023

Author, using data from S&P Capital IQ

CRM Valuation 24.02.2023

Author

CRM Actual Situation Weekly 23.02.2023

Author, using TradingView

CRM Likely Outcome 23.02.2023

Author, using TradingView


Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Additional disclosure: All of my articles are a matter of opinion and must be treated as such. All opinions and estimates reflect my best judgment on selected aspects of a potential investment in securities of the mentioned company or underlying, as of the date of publication. Any opinions or estimates are subject to change without notice, and I am under no circumstance obliged to update or correct any information presented in my analyses. I am not acting in an investment adviser capacity, and this article is not financial advice. This article contains independent commentary to be used for informational and educational purposes only. I invite every investor to do their research and due diligence before making an independent investment decision based on their particular investment objectives, financial situation, and risk tolerance. I take no responsibility for your investment decisions but wish you great success.


Leave a Reply

Your email address will not be published. Required fields are marked *